Serigne Lo Selected Research

Serigne Lo Research Topics

27	Melanoma (Melanoma, Malignant) 01/2024 - 11/2015
11	Neoplasms (Cancer) 08/2022 - 08/2012
11	Acute Kidney Injury (Acute Renal Failure) 01/2018 - 10/2009
8	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2017
6	Brain Neoplasms (Brain Tumor) 01/2022 - 01/2016
6	Critical Illness (Critically Ill) 10/2017 - 10/2009
3	Low Back Pain (Lumbago) 01/2021 - 01/2019
2	Chronic Renal Insufficiency 10/2014 - 06/2013
1	Disease Progression 01/2021
1	COVID-19 01/2021
1	Edema (Dropsy) 11/2020
1	Erythema 11/2020
1	Colitis 11/2020
1	Autoimmune Diseases (Autoimmune Disease) 11/2020
1	Margins of Excision 01/2019
1	Squamous Cell Carcinoma of Head and Neck 01/2019
1	Anus Neoplasms (Anal Cancer) 01/2019
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Fatigue 01/2019
1	Pain (Aches) 01/2019
1	Rheumatic Diseases (Rheumatism) 12/2018
1	AIDS-Related Complex (ARC) 07/2018
1	Arthrogryposis renal dysfunction cholestasis syndrome 07/2018
1	Uveal melanoma 01/2017
1	Clinical Deterioration 08/2015
1	Obesity 07/2015
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2015
1	Cataract (Cataracts) 08/2014
1	Catheter-Related Infections 07/2013
1	Acidosis 03/2013
1	Vascular Diseases (Vascular Disease) 08/2012
1	Hemorrhage 01/2012
1	Body Weight (Weight, Body) 10/2009

8	IpilimumabIBA 01/2022 - 01/2018
7	NivolumabIBA 01/2022 - 06/2017
6	AntibodiesIBA 01/2024 - 06/2017
5	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2024 - 11/2015
5	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2018
5	Immune Checkpoint InhibitorsIBA 05/2022 - 09/2017
2	Proteins (Proteins, Gene)FDA Link 11/2020 - 01/2014
2	trametinibIBA 01/2019 - 11/2015
2	dabrafenibIBA 01/2019 - 11/2015
2	pembrolizumabIBA 09/2017 - 06/2017
1	ChemokinesIBA 01/2023
1	LigandsIBA 01/2022
1	Apoptosis Regulatory ProteinsIBA 01/2022
1	salicylhydroxamic acid (SHAM)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	A 121IBA 01/2021
1	Infliximab (Remicade)FDA Link 11/2020
1	SteroidsIBA 11/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2020
1	Programmed Cell Death 1 ReceptorIBA 11/2020
1	Formaldehyde (Formol)FDA Link 01/2019
1	Circulating Tumor DNAIBA 01/2018
1	Heparin (Liquaemin)FDA LinkGeneric 08/2015
1	A 17 (A-17)IBA 08/2015
1	Citric Acid (Citrate)FDA LinkGeneric 08/2015
1	SolutionsIBA 01/2015
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2014
1	Mupirocin (Bactroban)FDA LinkGeneric 07/2013
1	AcidsIBA 03/2013
1	Gliclazide (Diamicron)IBA 08/2012
1	perindopril drug combination indapamideIBA 08/2012
1	Colloids (Colloid)IBA 01/2012
1	Crystalloid SolutionsIBA 01/2012
1	HES 130-0.4IBA 01/2012

24	Therapeutics 01/2024 - 10/2009
11	Immunotherapy 01/2024 - 11/2015
7	Continuous Renal Replacement Therapy 10/2017 - 10/2009
5	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2018 - 06/2012
3	Neoadjuvant Therapy 01/2021 - 01/2019
3	Radiotherapy 01/2019 - 01/2016
2	Aftercare (After-Treatment) 05/2022 - 01/2019
2	Critical Care (Surgical Intensive Care) 01/2021 - 02/2014
1	Adjuvant Radiotherapy 08/2022
1	Withholding Treatment 01/2022
1	Surgical Amputation (Amputations) 04/2019
1	Analgesia 01/2019
1	Magnetic Field Therapy 01/2019
1	Drug Therapy (Chemotherapy) 01/2017
1	Catheters 01/2016
1	Telescopes 08/2014
1	Eyeglasses (Spectacles) 08/2014
1	Refractive Surgical Procedures 08/2014
1	Peritoneal Dialysis 07/2013
1	Artificial Respiration (Mechanical Ventilation) 06/2013
1	Erythrocyte Transfusion 01/2012